Compare PAY & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAY | LNTH |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2021 | 2015 |
| Metric | PAY | LNTH |
|---|---|---|
| Price | $34.81 | $59.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $36.50 | ★ $74.17 |
| AVG Volume (30 Days) | 651.9K | ★ 1.2M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.09 | N/A |
| EPS | 0.47 | ★ 2.39 |
| Revenue | $1,123,926,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $36.74 | $0.01 |
| Revenue Next Year | $21.73 | $1.24 |
| P/E Ratio | $74.05 | ★ $24.98 |
| Revenue Growth | ★ 44.34 | 1.95 |
| 52 Week Low | $22.65 | $47.25 |
| 52 Week High | $40.43 | $111.29 |
| Indicator | PAY | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 64.06 |
| Support Level | $34.25 | $57.44 |
| Resistance Level | $35.18 | $59.30 |
| Average True Range (ATR) | 1.26 | 1.94 |
| MACD | -0.17 | 0.62 |
| Stochastic Oscillator | 45.50 | 96.63 |
Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.